[go: up one dir, main page]

NO20092567L - Acetylendenvater og deres anvendelse til binding og avbilding av amyloidplakker - Google Patents

Acetylendenvater og deres anvendelse til binding og avbilding av amyloidplakker

Info

Publication number
NO20092567L
NO20092567L NO20092567A NO20092567A NO20092567L NO 20092567 L NO20092567 L NO 20092567L NO 20092567 A NO20092567 A NO 20092567A NO 20092567 A NO20092567 A NO 20092567A NO 20092567 L NO20092567 L NO 20092567L
Authority
NO
Norway
Prior art keywords
imaging
endwaters
acetylene
bonding
methods
Prior art date
Application number
NO20092567A
Other languages
English (en)
Norwegian (no)
Inventor
Hank F Kung
Mei-Ping Kung
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO20092567L publication Critical patent/NO20092567L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/34—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
NO20092567A 2006-12-07 2009-07-06 Acetylendenvater og deres anvendelse til binding og avbilding av amyloidplakker NO20092567L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87324906P 2006-12-07 2006-12-07
US11/951,612 US7678819B2 (en) 2006-12-07 2007-12-06 Acetylene derivatives and their use for binding and imaging amyloid plaques
PCT/US2007/025177 WO2008073350A2 (fr) 2006-12-07 2007-12-07 Dérivés d'acétylène et leur utilisation pour lier et imager des plaques amyloïdes

Publications (1)

Publication Number Publication Date
NO20092567L true NO20092567L (no) 2009-09-04

Family

ID=39512287

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092567A NO20092567L (no) 2006-12-07 2009-07-06 Acetylendenvater og deres anvendelse til binding og avbilding av amyloidplakker

Country Status (16)

Country Link
US (1) US7678819B2 (fr)
EP (1) EP2089110A2 (fr)
JP (1) JP2010512325A (fr)
KR (1) KR20090090370A (fr)
AU (1) AU2007332818A1 (fr)
BR (1) BRPI0720590A2 (fr)
CA (1) CA2672187A1 (fr)
CO (1) CO6190627A2 (fr)
CR (1) CR10842A (fr)
EA (1) EA200970551A1 (fr)
IL (1) IL199201A (fr)
MX (1) MX2009006075A (fr)
NO (1) NO20092567L (fr)
NZ (1) NZ577458A (fr)
SV (1) SV2009003289A (fr)
WO (1) WO2008073350A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2247558T5 (pl) 2008-02-14 2024-10-14 Eli Lilly And Company Nowe środki obrazujące do wykrywania czynnościowych zaburzeń neurologicznych
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
US8420052B2 (en) 2008-07-24 2013-04-16 Siemens Medical Solutions Usa, Inc. Imaging agents useful for identifying AD pathology
PT2323696T (pt) * 2008-09-18 2018-11-20 Cedars Sinai Medical Center Método ótico para a deteção da doença de alzheimer
EP2411057B1 (fr) * 2009-03-23 2020-05-06 Eli Lilly and Company Agents d'imagerie pour détecter des troubles neurologiques
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
ES2620177T3 (es) 2009-10-15 2017-06-27 Guerbet Agentes de formación de imágenes y su uso para el diagnóstico in vivo de enfermedades neurodegenerativas, particularmente la enfermedad de Alzheimer y enfermedades derivadas
WO2012051170A2 (fr) * 2010-10-12 2012-04-19 Mayo Foundation For Medical Education And Research Imagerie de méningiomes en utilisant des dérivés de phingylbenzothiazole, stilbène, ou biphénylalcyne
CA2894994C (fr) * 2012-12-21 2019-11-12 National Institute Of Radiological Sciences Composes d'imagerie des proteines tau qui s'accumulent dans le cerveau
US9895324B2 (en) 2014-03-26 2018-02-20 University Of Kentucky Research Foundation Halogenated diarylacetylenes and methods of treating cancer
WO2016164531A2 (fr) 2015-04-08 2016-10-13 BioMendics, LLC Formulation et procédé permettant de moduler la cicatrisation de plaie
JP7456621B2 (ja) * 2018-08-07 2024-03-27 慶應義塾 神経機能調節物質の動態の検出剤、及び神経機能調節物質の検出方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4111990B4 (de) * 1990-04-19 2005-06-02 Merck Patent Gmbh Di- und Trifluortolane
JPH07324045A (ja) * 1994-05-27 1995-12-12 Seimi Chem Co Ltd トラン誘導体化合物およびそれを含有する液晶組成物
JPH0812599A (ja) * 1994-06-27 1996-01-16 Sumitomo Chem Co Ltd トラン化合物の製造法
JP2001089407A (ja) 1999-09-24 2001-04-03 Fuji Photo Film Co Ltd ジフェニルアセチレン化合物及び該化合物の製造方法
US6599945B2 (en) * 2000-08-15 2003-07-29 Northeastern Ohio Universities College Of Medicine Methods for treating subjects infected with a herpes virus
GB0127430D0 (en) * 2001-11-15 2002-01-09 Smithkline Beecham Corp Compounds
CN100338506C (zh) * 2002-01-21 2007-09-19 石家庄永生华清液晶有限公司 多稳态液晶材料显示器及其制备方法
WO2004046099A2 (fr) * 2002-02-01 2004-06-03 William Marsh Rice University Procede de fabrication d'interface molecule-surface
WO2004038374A2 (fr) * 2002-10-24 2004-05-06 Merck & Co., Inc. Derives d'alcyne utilises comme marqueurs pour la liaison au recepteur du glutamate metabotropique
US7022703B2 (en) * 2003-07-24 2006-04-04 Janssen Pharmaceutica, N.V. Acetylenic compound useful in treating inflammatory disorders
EP1729771B1 (fr) 2004-03-22 2009-10-14 Eli Lilly & Company Derives de pyridyle et leur utilisation en tant qu'antagonistes du recepteur de mglu5
US7951922B2 (en) * 2004-08-13 2011-05-31 National Institute Of Advanced Industrial Science And Technology Photoresponsive heterocyclic azo compound, method for producing the same, and optical information recording medium
JP2006089485A (ja) * 2004-08-24 2006-04-06 Santen Pharmaceut Co Ltd ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
WO2006113458A1 (fr) * 2005-04-15 2006-10-26 Bristol-Myers Squibb Company Inhibiteurs heterocycliques des proteines arginine methyle transferases
WO2006115895A2 (fr) 2005-04-22 2006-11-02 Merck & Co., Inc. Composes de phenylethyne

Also Published As

Publication number Publication date
WO2008073350A3 (fr) 2008-08-14
EA200970551A1 (ru) 2009-12-30
CA2672187A1 (fr) 2008-06-19
MX2009006075A (es) 2009-06-30
US7678819B2 (en) 2010-03-16
US20080166299A1 (en) 2008-07-10
SV2009003289A (es) 2009-10-02
JP2010512325A (ja) 2010-04-22
WO2008073350A2 (fr) 2008-06-19
BRPI0720590A2 (pt) 2014-04-08
CO6190627A2 (es) 2010-08-19
AU2007332818A1 (en) 2008-06-19
KR20090090370A (ko) 2009-08-25
IL199201A (en) 2013-05-30
EP2089110A2 (fr) 2009-08-19
CR10842A (es) 2009-10-13
NZ577458A (en) 2012-01-12

Similar Documents

Publication Publication Date Title
NO20092567L (no) Acetylendenvater og deres anvendelse til binding og avbilding av amyloidplakker
MX2007007380A (es) Derivados de estilbeno y su uso para estudios de union y por imagenes de placas amiloides.
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
MX2009006345A (es) Compuestos utiles como inhibidores de proteina cinasa.
NO20084435L (no) C-MET proteinkinaseinhibitorer
MX2009011810A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
MX2009012719A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
MX2009006690A (es) Aminopirimidinas utiles como inhibidores de proteinas cinasas.
WO2007095188A3 (fr) Dihydrodiazepines servant d'inhibiteurs des proteines kinases
ZA200707342B (en) Pyrrolopyrimidines useful as inhibitors of protein kinase
ZA200906264B (en) Aminopyrimidines useful as inhibitors of protein kinases
SG166828A1 (en) Aminopyrimidines useful as kinase inhibitors
MX2009009592A (es) Aminopiridinas utiles como inhibidores de proteinas cinasas.
MX2009010037A (es) Aminopirimidinas utiles como inhibidores de cinasas.
MX2009009590A (es) Aminopirimidinas utiles como inhibidores de proteinas cinasas.
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
TW200633980A (en) Pyridones useful as inhibitors of kinases
NO20084590L (no) Styrylpyridinderivater og deres anvendelse til binding og avbilding av amyloidplakker
WO2007087283A3 (fr) Thiophene-carboxamides utiles en tant qu'inhibiteurs de proteines kinases
WO2007120760A3 (fr) Thiophène-carboxamides servant d'inhibiteurs de protéines kinases
MX2009011811A (es) Aminopirimidinas utiles como inhibidores de cinasa.
WO2007139816A3 (fr) Thiophène-carboxamides pouvant être employés en tant qu'inhibiteurs de protéine kinase
TW200621721A (en) Methods of preparing indazole compounds
ATE542814T1 (de) Pyrazinkinaseinhibitoren
MX2010003563A (es) Inhibidores de proteina cinasa de c-met.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application